+
Site Tour

Search

Showing 51 - 60 of 459 results.

  • TAVI Summit 2024

    ON DEMAND - TAVI SUMMIT 2024 2nd Abbott Annual Transcatheter Aortic Valve Implantation Summit SESSION1: CARDIAC IMAGING IN AORTIC STENOSIS SESSION 2: REFINING TAVI: A LIVE DEMONSTRATION FROM BERLI

  • Clinical Data

    Tendyne™ TMVR improves your patients’ function and quality of life, with clinically significant improvement in a 6-minute walk test2 and Kansas City Cardiomyopathy Questionnaire (KCCQ) scores.1 The

  • Clinical Data

    EXCELLENT OUTCOMES IN CLINICAL TRIAL RESULTS LEARN MORE: CLINICAL INSIGHTS  TAVI in Small Annulus 30-DAY NAVITOR™1,2 N=120 EVOLUT‡ PRO3 N=60 ACURATE NEO

  • Clinical Data

    NYHA: New York Heart Association LEARN MORE: CLINICAL Trials   Clinical Case Compendium A SOLUTION THAT HAS RECEIVED CLOSE ATTENTION5–7, 10,11 — AND STRONGLY POSITIVE REVIEWS.12

  • Patients who benefit

    A STATE-OF-THE-ART TREATMENT OPTION FOR PATIENTS AT HIGH RISK FOR SURGERY TriClip™ TEER is a low risk,5 minimally invasive, non-surgical treatment option for symptomatic patients with severe Tricuspi

  • NAVITOR™ TAVI system features

    Large effective orifice areas.1,2 Single-digit gradients.1,2 30-day Echo Core Lab Data1,2 HEMODYNAMIC IMPACT Non-tapered stent and large effective orifice areas resulting in single-digit gradie

  • Voice of the experts

    STABLE DELIVERY. REMARKABLE PERFORMANCE. FUTURE READY.   STABLE DELIVERY REMARKABLE PERFORMANCE FUTURE READY WATCH ON DEMAND: TAVI Webinar 2025  TAVI SUMMIT 2024 &nbs

  • Clinical Data

    2-Year OUTCOMES from the triluminate pivotal trial New TriClip™ Transcatheter Edge-to-Edge Repair clinical data release   EXPLORE NOW INSPIRED BY PATIENTS. MADE POSSIBLE BY YOU. TriClip TE

  • Clinical Data

    MitraClip™ + GDMT patients were more likely to be in NYHA functional class I or II throughout the 5 years MitraClip™ + GDMT patients benefited from a 47% relative risk reduction in HFH/ Death versu

  • Therapy

    SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding LAA Occlusion HOW DOES IT WORK? SUPPORTED BY GUIDELINES, PROVEN BY DATA PROVEN R

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline